Infectivity and immune escape of the new SARS-CoV-2 variant of interest Lambda

@inproceedings{Acevedo2021InfectivityAI,
  title={Infectivity and immune escape of the new SARS-CoV-2 variant of interest Lambda},
  author={M{\'o}nica L. Acevedo and Luis Antonio Alonso-Palomares and Andr{\'e}s Bustamante and Aldo Gaggero and Fabio Paredes and Claudia P. Cort{\'e}s and Fernando Valiente-Echeverr{\'i}a and Ricardo Soto-Rifo},
  booktitle={medRxiv},
  year={2021}
}
Background: The newly described SARS-CoV-2 lineage C.37 was recently classified as a variant of interest by the WHO (Lambda variant) based on its high circulation rates in South American countries and the presence of critical mutations in the spike protein. The impact of such mutations in infectivity and immune escape from neutralizing antibodies are entirely unknown. Methods: We performed a pseudotyped virus neutralization assay and determined the impact of the Lambda variant on infectivity… 
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance
Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination
TLDR
The reduced neutralization ability of the Lambda variant suggests that the efficacy of monoclonal antibodies and vaccines may be compromised during the current pandemic.
Severity, Pathogenicity and Transmissibility of Delta and Lambda Variants of SARS-CoV-2, Toxicity of Spike Protein and Possibilities for Future Prevention of COVID-19
TLDR
Delta and Lambda variants demonstrate high infectivity and are less responsive to the immune response in vaccinated individuals, and future therapeutic strategies are discussed, including those based on high stability of epitopes, conservation of the N protein and the novel intracellular antibody receptor, tripartite-motif protein 21 (TRIM21) recognized by antibodies against the Nprotein.
The biological and clinical significance of emerging SARS-CoV-2 variants
The past several months have witnessed the emergence of SARS-CoV-2 variants with novel spike protein mutations that are influencing the epidemiological and clinical aspects of the COVID-19 pandemic.
Divergence of delta and beta variants and SARS-CoV-2 evolved in prolonged infection into distinct serological phenotypes
TLDR
It is concluded that beta and delta are serologically distant, further than each is from ancestral, and that virus evolved in prolonged infection during advanced HIV disease is serologically close to beta and far from delta.
Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy
TLDR
Existing evidence about newly emerged variants of SARS-CoV-2 are summarized and how well vaccines work against targeting new variants and modifications of highly flexible mRNA vaccines that might be required in the future are summarized.
Convergence of immune escape strategies highlights plasticity of SARS-CoV-2 spike
TLDR
The observed plasticity of the NTD foreshadows its broad potential for immune escape with the continued spread of SARS-CoV-2, and similar modifications became independently established in several other lineages, highlighting the possibility of a general escape mechanism via the N TD supersite.
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
TLDR
The neutralizing capacities of antibodies secreted by volunteers in the Chilean population immunized with CoronaVac against variants of concern and after SARS-CoV-2 infection are described, observing that the blocking capacity of antibodies from vaccinated volunteers increased up to ten times for all the variants tested.
SARS-CoV-2 Mutations and their Viral Variants
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 23 REFERENCES
SARS-CoV-2 variants, spike mutations and immune escape
TLDR
The literature on mutations of the SARS-CoV-2 spike protein, the primary antigen, is summarized, focusing on their impacts on antigenicity and contextualizing them in the protein structure, and discussed in the context of observed mutation frequencies in global sequence datasets.
Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile
TLDR
The data presented here represent the first insights into NAb responses in individuals from Chile, serving as a guide for future studies in the country.
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
TLDR
It is found that recurrent deletions overcome this slow substitution rate of Coronaviruses and are found to accelerate SARS-CoV-2 antigenic evolution and, more generally, drive adaptive evolution.
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections
TLDR
Overall, the expanding repertoire of NTD deletions throughout the pandemic and their association with case surges and vaccine breakthrough infections point to antigenic minimalism as an emerging evolutionary strategy for SARS-CoV-2 to evade immune responses.
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections
TLDR
Overall, the expanding repertoire of Spike protein deletions throughout the pandemic and their association with case surges and vaccine breakthrough infections point to antigenic minimalism as an emerging evolutionary strategy for SARS-CoV-2 to evade immune responses.
Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition
TLDR
A deep mutational scanning method is described to map how all amino-acid mutations in the RBD affect antibody binding, and a complete escape-mutation maps enable rational design of antibody therapeutics and assessment of the antigenic consequences of viral evolution.
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
TLDR
The rapid spread of VOC 202012/01 suggests that it transmits more efficiently from person to person than preexisting variants of SARS-CoV-2, which could lead to global surges in COVID-19 hospitalizations and deaths, so there is an urgent need to estimate how much more quickly this variant spreads.
...
1
2
3
...